ÂÜÀòÂÒÂ×

Morgan Cheatham is a Vice President at Bessemer Venture Partners, specializing in healthcare and life sciences with an emphasis on computational applications since 2017. In addition to this role, Morgan is a Co-Founder of Decoding Bio, a board member at the Coalition for Health AI, and a member of the NEJM AI Editorial Team. As an interim Chief Executive Officer and Board Director at FOLX Health, Morgan actively contributes to healthcare innovation. Morgan also serves as a Limited Partner at Silver Beech Capital Management and First Close Partners, focusing on intrinsic value-based investments and supporting underrepresented managers in venture capital. Recognized by Forbes as a member of the 30 Under 30 in Venture Capital in 2023, Morgan's earlier experience includes roles as an Investment Banking Analyst at Goldman Sachs and a Data Scientist at Kyruus. Morgan holds a Doctor of Medicine degree from The Warren Alpert Medical School of Brown University and a Bachelor of Science in Computational Decision Sciences from Brown University, complemented by a foundational education from Thomas Jefferson High School for Science and Technology.